153 related articles for article (PubMed ID: 12941766)
1. Critical roles of tumor necrosis factor-related apoptosis-inducing ligand in type 1 diabetes.
Lamhamedi-Cherradi SE; Zheng S; Tisch RM; Chen YH
Diabetes; 2003 Sep; 52(9):2274-8. PubMed ID: 12941766
[TBL] [Abstract][Full Text] [Related]
2. Blockade of tumor necrosis factor-related apoptosis-inducing ligand exacerbates type 1 diabetes in NOD mice.
Mi QS; Ly D; Lamhamedi-Cherradi SE; Salojin KV; Zhou L; Grattan M; Meagher C; Zucker P; Chen YH; Nagle J; Taub D; Delovitch TL
Diabetes; 2003 Aug; 52(8):1967-75. PubMed ID: 12882912
[TBL] [Abstract][Full Text] [Related]
3. Roles of TNF-related apoptosis-inducing ligand in experimental autoimmune encephalomyelitis.
Hilliard B; Wilmen A; Seidel C; Liu TS; Göke R; Chen Y
J Immunol; 2001 Jan; 166(2):1314-9. PubMed ID: 11145715
[TBL] [Abstract][Full Text] [Related]
4. A role of the TRAIL-TRAIL receptor system in the pathogenesis of diabetes.
Vaccarezza M; Delbello G; Zauli G
Acta Biomed; 2007; 78 Suppl 1():262-7. PubMed ID: 17465340
[TBL] [Abstract][Full Text] [Related]
5. Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL-/- mice.
Lamhamedi-Cherradi SE; Zheng SJ; Maguschak KA; Peschon J; Chen YH
Nat Immunol; 2003 Mar; 4(3):255-60. PubMed ID: 12577054
[TBL] [Abstract][Full Text] [Related]
6. Islet-specific expression of IL-10 promotes diabetes in nonobese diabetic mice independent of Fas, perforin, TNF receptor-1, and TNF receptor-2 molecules.
Balasa B; Van Gunst K; Jung N; Balakrishna D; Santamaria P; Hanafusa T; Itoh N; Sarvetnick N
J Immunol; 2000 Sep; 165(5):2841-9. PubMed ID: 10946317
[TBL] [Abstract][Full Text] [Related]
7. Role of tumor necrosis factor-related apoptosis-inducing ligand in immune response to influenza virus infection in mice.
Ishikawa E; Nakazawa M; Yoshinari M; Minami M
J Virol; 2005 Jun; 79(12):7658-63. PubMed ID: 15919918
[TBL] [Abstract][Full Text] [Related]
8. The involvement of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in atherosclerosis.
Michowitz Y; Goldstein E; Roth A; Afek A; Abashidze A; Ben Gal Y; Keren G; George J
J Am Coll Cardiol; 2005 Apr; 45(7):1018-24. PubMed ID: 15808757
[TBL] [Abstract][Full Text] [Related]
9. Involvement of tumor necrosis factor-related apoptosis-inducing ligand and tumor necrosis factor-related apoptosis-inducing ligand receptors in viral hepatic diseases.
Saitou Y; Shiraki K; Fuke H; Inoue T; Miyashita K; Yamanaka Y; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T
Hum Pathol; 2005 Oct; 36(10):1066-73. PubMed ID: 16226105
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression.
Song K; Chen Y; Göke R; Wilmen A; Seidel C; Göke A; Hilliard B; Chen Y
J Exp Med; 2000 Apr; 191(7):1095-104. PubMed ID: 10748228
[TBL] [Abstract][Full Text] [Related]
11. TRAIL and KILLER are expressed and induce apoptosis in the murine preimplantation embryo.
Riley JK; Heeley JM; Wyman AH; Schlichting EL; Moley KH
Biol Reprod; 2004 Sep; 71(3):871-7. PubMed ID: 15128592
[TBL] [Abstract][Full Text] [Related]
12. Critical contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to apoptosis of human CD4+ T cells in HIV-1-infected hu-PBL-NOD-SCID mice.
Miura Y; Misawa N; Maeda N; Inagaki Y; Tanaka Y; Ito M; Kayagaki N; Yamamoto N; Yagita H; Mizusawa H; Koyanagi Y
J Exp Med; 2001 Mar; 193(5):651-60. PubMed ID: 11238596
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor-related apoptosis-inducing ligand and CD56 expression in patients with type 1 diabetes mellitus.
Cheung SS; Metzger DL; Wang X; Huang J; Tai J; Tingle AJ; Ou D
Pancreas; 2005 Mar; 30(2):105-14. PubMed ID: 15714132
[TBL] [Abstract][Full Text] [Related]
14. IL-10 deficiency does not inhibit insulitis and accelerates cyclophosphamide-induced diabetes in the nonobese diabetic mouse.
Balasa B; Van Gunst K; Jung N; Katz JD; Sarvetnick N
Cell Immunol; 2000 Jun; 202(2):97-102. PubMed ID: 10896769
[TBL] [Abstract][Full Text] [Related]
15. Synergistic inhibition of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human pancreatic beta cells by Bcl-2 and X-linked inhibitor of apoptosis.
Ou D; Wang X; Metzger DL; James RF; Pozzilli P; Plesner A; Korneluk RG; Verchere CB; Tingle AJ
Hum Immunol; 2005 Mar; 66(3):274-84. PubMed ID: 15784465
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of chronic obstructive uropathy: increased expression of apoptosis-promoting molecules.
Choi YJ; Baranowska-Daca E; Nguyen V; Koji T; Ballantyne CM; Sheikh-Hamad D; Suki WN; Truong LD
Kidney Int; 2000 Oct; 58(4):1481-91. PubMed ID: 11012883
[TBL] [Abstract][Full Text] [Related]
17. Regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptor expression in human neutrophils.
Kamohara H; Matsuyama W; Shimozato O; Abe K; Galligan C; Hashimoto S; Matsushima K; Yoshimura T
Immunology; 2004 Feb; 111(2):186-94. PubMed ID: 15027904
[TBL] [Abstract][Full Text] [Related]
18. Enhanced proliferation and increased IFN-gamma production in T cells by signal transduced through TNF-related apoptosis-inducing ligand.
Chou AH; Tsai HF; Lin LL; Hsieh SL; Hsu PI; Hsu PN
J Immunol; 2001 Aug; 167(3):1347-52. PubMed ID: 11466352
[TBL] [Abstract][Full Text] [Related]
19. Implication of TNF-related apoptosis-inducing ligand in inflammatory intestinal epithelial lesions.
Begue B; Wajant H; Bambou JC; Dubuquoy L; Siegmund D; Beaulieu JF; Canioni D; Berrebi D; Brousse N; Desreumaux P; Schmitz J; Lentze MJ; Goulet O; Cerf-Bensussan N; Ruemmele FM
Gastroenterology; 2006 Jun; 130(7):1962-74. PubMed ID: 16762619
[TBL] [Abstract][Full Text] [Related]
20. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-gamma-dependent suppression of subcutaneous tumor growth.
Takeda K; Smyth MJ; Cretney E; Hayakawa Y; Yamaguchi N; Yagita H; Okumura K
Cell Immunol; 2001 Dec; 214(2):194-200. PubMed ID: 12088418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
